Episode

Episode Brief·YouTube

Why You Gain Belly Fat During Menopause (It's Not Just Aging!)

Mary Claire Haver

Watch on YouTube Add to chat My bookmarks ← All sources

TL;DR

The four things you'd lose by not watching

3 items

TL;DR

The four things you'd lose by not watching

3 items

Visceral fat increases from 8% to 20-23% of total body fat during menopause, independent of diet and exercise changes.

Loss of estrogen drives a vicious cycle of systemic inflammation that promotes visceral fat storage, which in turn amplifies inflammation.

Starting menopausal hormone therapy in perimenopause reduces the risk of progressing from pre-diabetes to full diabetes by 50%.

What's new

Personal practice updates, fresh positions, predictions

2 items

menopause-causes-visceral-fat-gain

Contrary to the wellness narrative that menopause doesn't cause weight gain, Dr. Haver argues that menopause triggers a dramatic shift in body composition, specifically a near-tripling of visceral fat, due to the loss of estrogen's anti-inflammatory effects.

Why this matters: Pushes back against the popular claim that menopause-related weight gain is entirely due to aging, highlighting a distinct metabolic and inflammatory mechanism.

Background

Many wellness influencers and even some medical perspectives assert that weight gain during menopause is no greater than in age-matched women, attributing it to overall aging rather than hormonal changes. This view often dismisses the role of estrogen loss.

Dr. Haver clarifies that while total weight may not differ dramatically from age-matched controls, menopause profoundly redistributes body fat. Pre-menopausal women have about 8% of body fat as visceral fat; post-menopause that rises to 20-23%, a near-tripling without any change in diet or exercise. This expansion is driven by the loss of estrogen, which normally suppresses systemic inflammation. Without estrogen, inflammatory markers like CRP and interleukins rise, which in turn signals the body to deposit fat in the abdominal cavity. That visceral fat itself secretes more inflammatory cytokines, creating a self-perpetuating feedback loop. Additionally, estrogen withdrawal impairs liver handling of cholesterol (raising LDL, lowering HDL) and alters glucose metabolism, leading to worsened insulin resistance, pre-diabetes, and full diabetes. She emphasizes that this is not just aging but a direct endocrine consequence of menopause.

So we are seeing expansion of the body fat compartment, especially in what we call the viscera in medicine, which you would call belly fat. This is a very specific type of fat that wraps around our internal organs, and it acts very differently than subcutaneous fat.

Also said

“a premenopausal woman on average of her total body fat about 8% is visceral. Take her through the menopause transition put her into menopause. We now go from 8% to about 20% to 23%. So almost tripling the amount of fat with not one single change in diet and exercise.”— Quantifies the magnitude of visceral fat increase during menopause, underscoring that it occurs independently of lifestyle changes.

“When we take estrogen away and out of the system, several things start happening. Estrogen is a powerful anti-inflammatory hormones. So we see systemic inflammatory markers rise... we end up in this really crazy negative feedback cycle. More inflammation driving more fat to the abdomen causing more inflammation.”— Explains the mechanistic link between estrogen loss, inflammation, and visceral fat accumulation.

hormone-therapy-reduces-diabetes-risk

Menopausal hormone therapy (not birth control pills) in perimenopause significantly reduces the risk of developing full diabetes in women with pre-diabetes.

Why this matters: Offers a concrete, evidence-based benefit of HRT specifically for metabolic health during the menopause transition, beyond the usual bone and symptom relief narratives.

Background

The link between menopause and glucose dysregulation is under-recognized. Many women and even providers are unaware that estrogen loss directly increases insulin resistance and diabetes risk.

Dr. Haver points out that menopause fundamentally alters glucose metabolism, leading to higher rates of insulin resistance and progression to diabetes. She cites data showing that starting menopausal hormone therapy in perimenopause can cut the risk of developing full diabetes by half in women who are already pre-diabetic. She makes a critical distinction between menopausal hormone therapy (bioidentical or traditional) and birth control pills, implying the latter do not confer the same benefit. This positions HRT as not only for symptom management but as a potential preventive intervention for metabolic disease in midlife women.

a woman with pre-diabetes who is started on hormone therapy, not birth control pills, but menopausal hormone therapy in perimenopause, who is pre-diabetic, has a 50% decrease risk of developing full diabetes versus a woman not on HRT.

Recommendations

Products, supplements, and tools mentioned in the episode

1 item

Menopausal Hormone Therapy

Practice

For perimenopausal women with pre-diabetes, Dr. Haver highlights the metabolic protective effect of menopausal hormone therapy, reducing diabetes progression by 50%.

She stresses the importance of using menopausal hormone therapy rather than birth control pills, suggesting that the specific type and timing matter. This recommendation aligns with a broader shift in menopausal medicine to consider metabolic and cardiovascular benefits in addition to symptom relief.

vs alternatives

Distinguished from birth control pills; menopausal hormone therapy uses different doses and hormone types that are more appropriate for the perimenopausal metabolic context.

menopausal hormone therapy in perimenopause, who is pre-diabetic, has a 50% decrease risk of developing full diabetes versus a woman not on HRT.

Find Menopausal

Notable quotes

Lines worth pulling out — contrarian, specific, or perfectly phrased

4 items

Visceral fat expands dramatically across the menopause transition. And there is no denying this.

A firm, unambiguous statement contradicting those who dismiss menopause as a cause of belly fat.

we end up in this really crazy negative feedback cycle. More inflammation driving more fat to the abdomen causing more inflammation.

Vivid description of the vicious cycle that makes visceral fat self-perpetuating.

a premenopausal woman on average of her total body fat about 8% is visceral. Take her through the menopause transition put her into menopause. We now go from 8% to about 20% to 23%. So almost tripling the amount of fat with not one single change in diet and exercise.

Concrete statistic that illustrates the magnitude of the change, making the point that it's not just aging.

a woman with pre-diabetes who is started on hormone therapy, not birth control pills, but menopausal hormone therapy in perimenopause, who is pre-diabetic, has a 50% decrease risk of developing full diabetes versus a woman not on HRT.

Provides a powerful, specific benefit of HRT with a quantifiable outcome.

Sign in to share feedback

Tell us if this brief hit the mark or missed it — feedback feeds back into the next iteration of the prompt.

Topics covered

visceral-fatmenopause-weight-gainestrogen-inflammationinsulin-resistancehormone-therapycholesterolbody-compositionmetabolic-syndrome

Free account

Make this library yours

Reading is free for everyone. A free account adds the personal layer: save protocols, follow experts, and see how the other experts weigh in on this same topic.

Create a free account Sign in

Educational summary of the cited expert source — not medical advice. Open the source recording linked above and consult a qualified physician before acting on any protocol.